Compounds > mycaminose
Page last updated: 2024-12-08

mycaminose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID160504
CHEBI ID32569
SCHEMBL ID489383
MeSH IDM0061493

Synonyms (12)

Synonym
CHEBI:32569 ,
3,6-dideoxy-3-dimethylamino-d-glucose
3,6-dideoxy-3-(dimethylamino)-d-glucose
mycaminose ,
519-21-1
(2r,3s,4s,5r)-3-(dimethylamino)-2,4,5-trihydroxyhexanal
3678h27z8l ,
unii-3678h27z8l
mycaminose [mi]
SCHEMBL489383
DTXSID70199854
Q27114994

Research Excerpts

Overview

D-Mycaminose is an unusual dideoxy sugar found attached to the antibiotic tylosin, a commonly used veterinarian therapeutic.

ExcerptReferenceRelevance
"d-Mycaminose is an unusual dideoxy sugar found attached to the antibiotic tylosin, a commonly used veterinarian therapeutic. "( Molecular architecture of TylM1 from Streptomyces fradiae: an N,N-dimethyltransferase involved in the production of dTDP-D-mycaminose.
Carney, AE; Holden, HM, 2011)		1.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
glucosaminesAny hexosamine that is glucose in which at least one of the hydroxy groups has been replaced by an amino group.
deoxyglucose derivativeA deoxyhexose derivative that is formally obtained from deoxyglucose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's2 (12.50)18.2507
2000's8 (50.00)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.63 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
formaldehyde
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy		2.0810aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
erythromycin
Erythromycin: A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin : Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus).. erythromycin A : An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.		2.0810cyclic ketone;
erythromycin
galactose
aldohexose : A hexose with a (potential) aldehyde group at one end.		2.0810
desosamine
desosamine: RN given for (D-xylo)-isomer; structure in first source		7.7230amino sugar
mycarose
mycarose: RN given refers to (L-ribo)-isomer; structure given in first source; epi-axenose to lyxo configeration		2.0810dideoxyhexose derivative
forosamine
forosamine: from spiramycin; structure		2.0810hexosamine;
tetradeoxyhexose derivative
glucosamine
D-glucosamine : An amino sugar whose structure comprises D-glucose having an amino substituent at position 2.. 2-amino-2-deoxy-D-glucopyranose : A D-glucosamine whose structure comprises D-glucopyranose having an amino substituent at position 2.		4.15160D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
glycosides
[no description available]		1.9510
sf 837
midecamycin: minor descriptor (75-80); on-line search LEUCOMYCINS (75-80); Index Medicus search ANTIBIOTICS (75-80); macrolide antibiotic		2.0310organic molecular entity
platenolide i
platenolide I: from Streptomyces platensis; RN & N1 from 9th CI; see also platenolide II: 52212-95-0		2.0810
cc 1065
CC 1065: from Streptomyces zelensis; structure in second sourc		1.9510
protylonolide
protylonolide: structure in first source. tylactone : A 16-membererd macrolide that is the aglycone of the antibiotic 5-O-beta-D-mycaminosyltylactone.		2.420diol;
enone;
macrolide		metabolite
olivose
olivose: RN given for (D)-isomer		2.0810hexose
s-adenosylmethionine
(R)-S-adenosyl-L-methionine : An S-adenosyl-L-methionine that has R-configuration.. S-adenosyl-L-methionine zwitterion : A zwitterionic tautomer of S-adenosyl-L-methionine arising from shift of the proton from the carboxy group to the amino group.. (R)-S-adenosyl-L-methionine zwitterion : An S-adenosyl-L-methionine zwitterion that has R-configuration; major species at pH 7.3.. (S)-S-adenosyl-L-methionine zwitterion : An S-adenosyl-L-methionine zwitterion that has S-configuration; major species at pH 7.3.. S-adenosyl-L-methionine : A sulfonium compound that is the S-adenosyl derivative of L-methionine. It is an intermediate in the metabolic pathway of methionine.		2.2110organic cation;
sulfonium compound		coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
tylosin
[no description available]		2.6930
ConditionIndicatedRelationship StrengthStudiesTrials